Evidence map›Paper›PMID 24109227›Full record

ArticleJournal of virology2013

Efficiency of cell-free and cell-associated virus in mucosal transmission of human immunodeficiency virus type 1 and simian immunodeficiency virus.

Dror Kolodkin-Gal, Sandrine L Hulot, Birgit Korioth-Schmitz, Randi B Gombos, Yi Zheng, Joshua Owuor, Michelle A Lifton, Christian Ayeni, Robert M Najarian, Wendy W Yeh and 3 more

Abstract read
In one paragraph

Article in Journal of virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. CD8Nature reviews. Immunology · 2020
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Efficient HIV-1Open forum infectious diseases · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dror Kolodkin-GalBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Sandrine L Hulot
Birgit Korioth-Schmitz
Randi B Gombos
Yi Zheng
Joshua Owuor
Michelle A Lifton
Christian Ayeni
Robert M Najarian
Wendy W Yeh
Mohammed Asmal
Gideon Zamir
Norman L Letvin

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
NIAID NIH HHS AI060354NIAID NIH HHS P30 AI060354
6 · The paper itself

Abstract

Effective strategies are needed to block mucosal transmission of human immunodeficiency virus type 1 (HIV-1). Here, we address a crucial question in HIV-1 pathogenesis: whether infected donor mononuclear cells or cell-free virus plays the more important role in initiating mucosal infection by HIV-1. This distinction is critical, as effective strategies for blocking cell-free and cell-associated virus transmission may be different. We describe a novel ex vivo model system that utilizes sealed human colonic mucosa explants and demonstrate in both the ex vivo model and in vivo using the rectal challenge model in rhesus monkeys that HIV-1-infected lymphocytes can transmit infection across the mucosa more efficiently than cell-free virus. These findings may have significant implications for our understanding of the pathogenesis of mucosal transmission of HIV-1 and for the development of strategies to prevent HIV-1 transmission.

Indexed as

AnimalsColonHIV-1HIV InfectionsHumansIntestinal MucosaIn Vitro TechniquesMacaca mulattaSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency Virus

Identifiers

PMID24109227
PMCPMC3838232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.